# ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

> **NCT00385021** · PHASE2 · TERMINATED · sponsor: **Southwestern Regional Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** 5-Fluorouracil, leucovorin, oxaliplatin, avastin

## Key facts

- **NCT ID:** NCT00385021
- **Lead sponsor:** Southwestern Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2007-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385021, "ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00385021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*